Diva Laboratories (ROCO:4153) Total Stockholders Equity : NT$964.3 Mil (As of Mar. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Diva Laboratories Total Stockholders Equity?

Diva Laboratories's Total Stockholders Equity for the quarter that ended in Mar. 2025 was NT$964.3 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Diva Laboratories's Book Value per Share for the quarter that ended in Mar. 2025 was NT$16.44. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Diva Laboratories's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.00.

Diva Laboratories Total Stockholders Equity Historical Data

The historical data trend for Diva Laboratories's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diva Laboratories Total Stockholders Equity Chart

Diva Laboratories Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

988.89

986.42

1,016.18

1,032.80

1,055.50

Diva Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															985.18	1,019.18	1,031.71	1,055.50	964.27

Diva Laboratories (ROCO:4153) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Diva Laboratories's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(964.27	-	0)	/	58.668
	=	16.44

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Diva Laboratories's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2.554	+	2.258)	/	964.27
	=	0.00

Diva Laboratories Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Diva Laboratories's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Diva Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Diva Laboratories Ltd (ROCO:4153) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongshan Road, 9F, No. 351, Sector 2, Zhonghe District, New Taipei City, TWN, 235

Website

http://www.diva.com.tw

Diva Laboratories Ltd is a Taiwan-based company that engages in the sale, manufacturing, and development of medical equipment and computer-related devices. It offers endo/surgical displays; color displays for radiology and medical imaging services; touch displays; and original design manufacturing and original equipment manufacturing solutions.

Diva Laboratories Headlines

No Headlines